1
2
3
4
Erschienen: Rockville, MD,
Agency for Healthcare Research and Quality,
March 2020
Evidence synthesis
- number 188
von
Chou, R.
5
6
7
8
9
10
Clinical review report : Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)
Erschienen: Ottawa (ON),
Canadian Agency for Drugs and Technologies in Health,
February 2018
Version: final.